Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital (original) (raw)
Investigation of Glycopeptide Susceptibility of Coagulase-Negative Staphylococci (CoNS) from a Tertiary Care Hospital in Gorgan, Northern Iran
ezzat ghaemi
Archives of Pediatric Infectious Diseases, 2016
View PDFchevron_right
Current status of Glycopeptide intermediate and heterogenous Glycopeptide intermediate Staphylococcus aureus and their prevailing susceptibility pattern at two tertiary care hospitals of Pakistan
Fatima Kaleem
International Journal of Infectious Diseases, 2012
View PDFchevron_right
Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides
Rosangela Cereda, Iraci Tosin
Diagnostic Microbiology and Infectious Disease, 1999
View PDFchevron_right
PREVALENCE OF HETEROGENEOUS GLYCOPEPTIDE INTERMEDIATE RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Manu Chaudhary
American Journal of Infectious Diseases, 2013
View PDFchevron_right
PREVALENCE OF HETEROGENEOUS GLYCOPEPTIDE INTERMEDIATE RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Manu Chaudhary
View PDFchevron_right
Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening
Thais Souto-padrón
International Journal of Antimicrobial Agents, 2006
View PDFchevron_right
Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains
Jacques Schrenzel
Journal of Microbiological Methods, 2004
View PDFchevron_right
Glycopeptide resistance in Staphylococcus aureus
Stephanie Dancer
Journal of Antimicrobial Chemotherapy, 2003
View PDFchevron_right
First Detection of an Invasive Staphylococcus aureus Strain (D958) with Reduced Susceptibility to Glycopeptides in Saudi Arabia
Patrice Francois
Journal of Clinical Microbiology, 2010
View PDFchevron_right
Epidemiological and molecular characterization of Staphylococcus haemolyticus strains, from a hematology ward, with decreased susceptibility to glycopeptides
Sonam Wangchuk
Canadian Journal of Microbiology, 2011
View PDFchevron_right
Erratum to: Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital
YAŞAR NAKİPOĞLU
BMC Infectious Diseases, 2005
View PDFchevron_right
A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital
Fabien Garnier
Journal of Antimicrobial Chemotherapy, 2005
View PDFchevron_right
Detection of glycopeptide resistance in clinical isolates of Gram-positive bacteria
Ian Harding
Journal of Antimicrobial Chemotherapy, 1991
View PDFchevron_right
Investigation of Reduced Susceptibility to Glycopeptides among Methicillin-Resistant Staphylococcus aureus Isolates from Patients in Ireland and Evaluation of Agar Screening Methods for Detection of Heterogeneously Glycopeptide-Intermediate S. aureus
Margaret Fitzgibbon
Journal of Clinical Microbiology, 2007
View PDFchevron_right
Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected US hospitals
Marcel El Achkar
Journal of clinical …, 1999
View PDFchevron_right
Outbreak of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Glycopeptides in a Parisian Hospital
Ahmed Abdelaziz
2000
View PDFchevron_right
First detected isolate of glycopeptide-intermediate resistant Staphylococcus aureus in a renal unit at a central academic hospital in KwaZulu-Natal
Koleka Mlisana
View PDFchevron_right
First detected isolate of glycopeptide-intermediate resistant Staphylococcus aureus in a renal unit at a central academic hospital in KwaZulu-Natal: brief report
Koleka Mlisana
View PDFchevron_right
A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA)
Johan Mouton, Robin Howe, Paul Krabbe
Annals of Clinical Microbiology and Antimicrobials, 2007
View PDFchevron_right
Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates
Floriana Campanile
International Journal of Antimicrobial Agents, 2010
View PDFchevron_right
In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis
Carlos De Paz
Journal of Medical Microbiology, 2009
View PDFchevron_right
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals
Katie Greenland
Clinical Microbiology and Infection, 2005
View PDFchevron_right
Glycopeptide Resistance among Coagulase‐Negative Staphylococci that Cause Bacteremia: Epidemiological and Clinical Findings from a Case‐Control Study
Teresa Spanu
Clinical Infectious Diseases, 2001
View PDFchevron_right
High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus
Louis Bernard
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right